Limitations, agreements, and source contact

Phase II Study of Gemcitabine+Romidepsin in the Relapsed/Refractory Peripheral T-cell Lymphoma Patients · Source last updated 2019-10-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

point Of Contact

email

pierluigi.zinzani@unibo.it/lisa.argnani@unibo.it

organization

Policlinico S.Orsola-Malpighi - Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Via Massarenti, 9-40138 Bologna, Italy

phone

+39 0516364042

title

Zinzani Pier Luigi/Argnani Lisa

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice